INOVIO to Participate in December Investor Conferences
Rhea-AI Summary
INOVIO (NASDAQ:INO) will participate in two investor conferences in New York in December 2025. Management will appear at the Piper Sandler 37th Annual Healthcare Conference on Tuesday, December 2 for an 8:30–8:55 AM ET fireside chat (live webcast and 90‑day replay available) and at the Oppenheimer Movers in Rare Disease Summit on Thursday, December 11 for a 12:05–12:25 PM ET panel featuring elevator pitches of near‑term catalysts. Members of INOVIO management will also hold one‑on‑one investor meetings during both events.
Webcast link for the Piper Sandler presentation: https://bit.ly/44af19l.
Positive
- None.
Negative
- None.
News Market Reaction 2 Alerts
On the day this news was published, INO declined 4.55%, reflecting a moderate negative market reaction. Our momentum scanner triggered 2 alerts that day, indicating moderate trading interest and price volatility. This price movement removed approximately $6M from the company's valuation, bringing the market cap to $132M at that time.
Data tracked by StockTitan Argus on the day of publication.
Piper Sandler 37th Annual Healthcare Conference (
Date: Tuesday, December 2
Time: 8:30-8:55 AM ET
Format: Fireside Chat
Webcast: https://bit.ly/44af19l (live webcast and replay available for 90 days after the event)
Oppenheimer Movers in Rare Disease Summit (
Date:
Thursday, December 11
Time:
12:05-12:25 PM ET
Format: Panel - Elevator Pitches from Rare Disease Companies with Key Near-Term, Potentially Stock-Moving Catalysts
Members of INOVIO's management team will also be conducting one-on-one meetings with investors during these conferences.
About INOVIO
INOVIO is a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases. INOVIO's technology optimizes the design and delivery of innovative DNA medicines that teach the body to manufacture its own disease-fighting tools. For more information, visit www.inovio.com.
Contacts
Media: Jennie Willson, (267) 429-8567, communications@inovio.com
Investors: Peter Vozzo, ICR Healthcare, (443) 213-0505, investor.relations@inovio.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/inovio-to-participate-in-december-investor-conferences-302618252.html
SOURCE INOVIO Pharmaceuticals, Inc.
FAQ
When will INOVIO (INO) present at the Piper Sandler 37th Annual Healthcare Conference?
Where can I watch the INOVIO (INO) Piper Sandler webcast and replay?
When and what is INOVIO (INO) doing at the Oppenheimer Movers in Rare Disease Summit?
Will INOVIO (INO) management meet investors at the December conferences?
How long will the Piper Sandler INOVIO (INO) replay be available after the event?
